EvokAI Creative Labs Inc ( (TSE:OKAI) ) just unveiled an update.
EvokAI Creative Labs Inc. announced a 10:1 share consolidation effective February 5, 2025, which will reduce the number of its outstanding common shares to approximately 7.6 million. The company believes this move will increase financial community interest, broaden its investor base, improve trading liquidity, and reduce transaction costs for shareholders.
More about EvokAI Creative Labs Inc
EvokAI Creative Labs Inc. is a MedTech AI-powered company focused on developing innovative technologies for the healthcare sector. It uses machine learning models to analyze medical data, enhancing health outcomes, patient experiences, drug development, and clinical decision-making. The company operates across various segments of the healthcare system, including hospitals, clinics, research institutions, pharmaceutical companies, and more.
YTD Price Performance: 0%
Average Trading Volume: 23,110
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$885.8K
For an in-depth examination of OKAI stock, go to TipRanks’ Stock Analysis page.